Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2014/02/004432
CTRI/2014/02/004432CompletedPhase 4

An open, prospective, single centre study to assess the confidence, usability, preference and satisfaction on use of Zerostat-VT Spacer in healthy volunteers and in subjects with mild asthama or COPD

Cipla Ltd0 sites30 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Cipla Ltd
Enrollment
30
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1. Subjects and healthy volunteers willing to sign ethics committee
  • •approved informed consent form.
  • •2. Subjects and healthy volunteers of 18 years and above.
  • •3. Subjects with or without a respiratory condition. Each subject with a
  • •respiratory condition (prior experience of using a device) should be
  • •matched as far as possible with an individual without a respiratory
  • •condition (device naive) with respect to the age, sex, literacy status
  • •4. Subjects with mild Asthma or COPD or healthy volunteer.

Exclusion Criteria

  • •1. Subjects already using Zerostat-VT spacer prior to start of the study.
  • •2. Subjects with co-ordination problems like Parkinsonâ??s disease,
  • •mental illness, tremors etc.

Investigators

Sponsor
Cipla Ltd

Similar Trials

Completed
Phase 4
Study to assess the confidence, usability,preference and satisfaction on use of Zerostat spacer in healthy volunteersand in subjects with mild Asthma or COPD.
CTRI/2014/03/004448Cipla Ltd30
Completed
Phase 4
A clinical trial to assess the confidence, usability, preference and satisfaction on use of Baby Mask with valve from parents of children who are healthy or who have mild Asthma.
CTRI/2009/091/000958Cipla Ltd30
Completed
Phase 4
Study to assess the confidence, usability,preference and satisfaction on use of Zerostat-V spacer in healthy volunteersand in subjects with mild Asthma or COPD.
CTRI/2014/03/004462Cipla Ltd30
Completed
Phase 4
A clinical trial to assess the confidence, usability, preference and satisfaction on use of peak flow master in healthy volunteers and in subjects with mild Asthma or COPD.
CTRI/2009/091/000586Cipla Ltd30
Active, not recruiting
Phase 1
Open, prospective, single-center study evaluating the efficacy and safety of 0.05% ingénol mebutate (Picato® 500) in the treatment of basal cell carcinomaStudy PICABAS
EUCTR2017-004608-22-FRCHU de Nice28